Industry: Healthcare | Publish Date: 06-Dec-2024 | No of Pages: 101 | No. of Tables: 71 | No. of Figures: 36 | Format: PDF | Report Code : HC1270
The Japan Dialysis Market size was valued at USD 2.86 billion in 2023, and is expected to reach USD 3.89 billion by 2030, with a CAGR of 4.5% from 2024 to 2030.
Japan dialysis market is a segment of the healthcare sector focused on providing artificial kidney functions to individuals with impaired renal function. Dialysis is a life-sustaining medical procedure used to manage patients with end-stage renal disease (ESRD) or acute kidney injuries.
This market includes various products and services such as hemodialysis and peritoneal dialysis equipment, dialysis consumables, and associated pharmaceuticals. Given the growing prevalence of kidney-related disorders and the increasing aging population, the market is crucial in delivering essential renal care, aiming to enhance patients' quality of life and improve overall healthcare outcomes.
The escalating healthcare expenditure is a pivotal driver for the Japan dialysis market, fostering increased investments in renal care infrastructure. As countries allocate substantial resources to enhance their healthcare systems, the expansion of dialysis services becomes a focal point.
This augmented financial commitment translates into improved accessibility to dialysis facilities, upgraded medical equipment, and enhanced patient care. The growing healthcare expenditure underscores a collective effort to address the rising prevalence of kidney-related ailments, further propelling the demand for dialysis treatments and positively impacting the overall market dynamics.
The surge in diabetes and hypertension cases in the country contributes significantly to the growth of the market. These chronic conditions, especially when unmanaged, can lead to kidney damage and eventually chronic kidney disease (CKD).
With the increasing prevalence of diabetes and hypertension, there is a corresponding rise in the incidence of CKD, necessitating the use of dialysis as a crucial therapeutic intervention. The expanding patient pool with these comorbidities underscores the importance of dialysis services in managing kidney-related complications, driving the demand for dialysis treatments.
One of the significant challenges in Japan dialysis market is the inherent risk of infections and complications associated with these procedures. Gap in adherence to stringent hygiene practices and inadequate sterilization measures can elevate the effect of infections, posing a threat to patient health. Additionally, complications arising from the dialysis process itself can contribute to treatment challenges.
The emergence of wearable and portable dialysis devices stands as a groundbreaking advancement in dialysis technology, offering a transformative opportunity for the dialysis market. These compact systems, resembling small backpacks, empower patients with unprecedented mobility and flexibility in their treatment schedules.
For instance, AWAK Technologies (AWAK), an innovative medical technology firm specializing in dialysis using regenerative technology for end-stage renal disease, revealed that the U.S. Food and Drug Administration (FDA) conferred the breakthrough device designation upon its AWAK Peritoneal Dialysis (AWAK PD) device.
This device, which is both wearable and highly portable, incorporates AWAK's patented sorbent technology. As technology continues to advance, we can anticipate further innovations in dialysis technology, ultimately leading to even better outcomes for patients.
Several market players operating in the Japan dialysis market include Baxter International, Inc., DaVita Inc., Nikkiso Co. Ltd., NxStage Medical, Inc., Asahi Kasei Corporation, Medicators, Inc, Fresenius Medical Care AG & Co. KGaA, Nipro Corporation, B. Braun Avitum AG, Diaverum Deutschland GmbH, and others.
Hemo Dialysis
Peritoneal Dialysis
Equipment
Consumables
Drugs
Services
In-center Dialysis
Home Dialysis
REPORT SCOPE AND SEGMENTATION:
Parameters |
Details |
Market Size in 2023 |
USD 2.86 Billion |
Revenue Forecast in 2030 |
USD 3.89 Billion |
Growth Rate |
CAGR of 4.5% from 2024 to 2030 |
Analysis Period |
2023–2030 |
Base Year Considered |
2023 |
Forecast Period |
2024–2030 |
Market Size Estimation |
Billion (USD) |
Growth Factors |
|
Companies Profiled |
10 |
Market Share |
Available for 10 companies |
Customization Scope |
Free customization (equivalent up to 80 working hours of analysts) after purchase. Addition or alteration to country, regional, and segment scope. |
Pricing and Purchase Options |
Avail customized purchase options to meet your exact research needs. |
Baxter International, Inc.
DaVita Inc.
Nikkiso Co. Ltd.
NxStage Medical, Inc.
Asahi Kasei Corporation
Medicators, Inc.
Fresenius Medical Care AG & Co. KGaA
Nipro Corporation
B. Braun Avitum AG
Diaverum Deutschland GmbH